top of page

AI in healthcare is being decided right now. Lead, or follow.
This is where you choose.

2nd AI Health Summit

The second annual AI in health summit will build on last year's inaugural event, focusing on how uptake of the technology has advanced across the health system and the future opportunities and risks that will need to be managed.

WHEN:
9 November 2026
WHERE:
The Establishment Ballroom,
George Street, Sydney

Post-Budget Summit

The half-day summit will discuss the implications of the Labor federal government's first Budget and the progress of other policy initiatives, including the National Medicines Policy and health technology assessment reviews.

About The Event

The second annual AI in Health Summit aims to build on the success of last year's inaugural event.

 

This year's focus will include:

  • Advancements in the uptake of AI technology by across the industry and broader health system

  • Future opportunities presented by AI

  • Risks associated with AI implementation that need to be managed

 

Key Themes:

  • Technological advancements

  • Opportunities for better outcomes

  • Risk management strategies

 

Participants can expect in-depth discussions and insights into how AI is shaping the future of healthcare.

About

150+

8

PARTICIPANTS
SESSIONS
Speakers

Sessions & Speakers

Aurealia Cohn.png
Aurelia Cohn

Group Digital and AI Transformation Lead, The Ward Marketing Group

​

Will AI industrialise care, or re-humanise it?


Aurelia's argument is uncomfortable: the real risk of AI isn't that it replaces us, it's that we use it to make a broken system produce more, faster, when it could be doing something genuinely useful.

Expect a case for shifting from efficiency to expansion, and from tech-first to people-first.

Ed Hollywood.png
Ed Hollywood

General Manager and Head of Human Pharmaceuticals ANZ, Boehringer Ingelheim

 

The genesis of the Patient Input Buddy, and what it means for decision-making​

​

Boehringer Ingelheim built Patient Input Buddy with the Patient Voice Initiative, Lung Foundation Australia, Scleroderma Australia and Rare Cancers Australia, to bring patient input directly into medicine evaluations.

Ed will unpack what it's already changing, and what it says about where health technology assessment is headed.

PANEL SESSION: New world of AI-powered advocacy

Paul.png
Paul Cross 

Founder, Managing Director and Publisher of Daily Dispatch​

​

Paul is Founder, Managing Director and Publisher of Daily Dispatch, home to BioPharmaDispatch and BiotechDispatch, two of Australia's leading independent platforms on health and life sciences policy. A former ministerial adviser to two federal Health Ministers, he went on to hold senior pharmaceutical industry roles in Australia and the US, giving him a rare vantage point across health policy, trade and commercial strategy. He holds a Bachelor of Laws and a Master of Arts, and is known for sharp commentary on HTA, pharmaceutical pricing and the politics of health reform.

Sally.png
Sally Mackenzie 

Founder and Managing Director of Delta Advisory and co-founder of Hansa AI​

​

Sally has worked across the private and public sectors in Australia and Asia-Pacific, including roles as Government Relations Executive at Australia Post and GR Principal at Telstra, before founding Delta Advisory. She is also co-founder of Hansa AI, a political intelligence platform that helps government relations professionals track issues and stakeholders, and drafts the briefs and submissions that follow. A former diplomat with postings in Indonesia and Solomon Islands, she has advised the Thai, Philippine and Mongolian governments, and serves as a non-executive director of Regional Australia Bank and President of the Australian Professional Government Relations Association.

Danielle.png
Danielle Ozolins

Founder, Patient Influence Network​

​

Danielle brings a rare perspective across healthcare, technology and lived patient experience, having moved from a career in healthcare into senior marketing and technology leadership. A pancreatic cancer diagnosis in 2024 gave her a first-hand view of how hard the health system can be to navigate, from treatment decisions to influencing change as a patient. As Founder of Patient Influence Network, she works to strengthen how healthcare listens to and involves patients in decisions that affect them, exploring how AI and emerging technology can amplify patient voice without replacing it.

PANEL SESSION: The Year AI Stopped Being Optional - One year on - facilitated by Paul Cross

Last year at this Summit, Sanofi's leaders called AI the industry's "industrial revolution, or bigger" and said it had stopped being a pilot and become the operating system for how work gets done. Leaders could no longer delegate it. They had to show up, set the standard and own the outcomes.

​

One year on, the team from Sasnofi return to say what held up, what had to be rethought, and where regulation and reputation risk now sit. If you want to know what "AI as an expectation" looks like after twelve months, this is the session.

Liz.png
Liz Selby

Country Lead and Head of Pharma ANZ - Sanofi​

​

Country Lead and Head of Pharma for Sanofi Australia and New Zealand, appointed permanently in November 2024 after a decade-plus at Sanofi, most recently as General Manager of Specialty Care. A former neonatal intensive care nurse with more than 25 years in healthcare, she now runs the combined pharma unit spanning immunology, diabetes, rare disease and rare blood disorders.

​

​

Luke.png
Luke Cornish

Head of Corporate Affairs - Sanofi​

​

Head of Corporate Affairs at Sanofi in Sydney since October 2024. He previously spent nearly five years at MSD and Organon in access and external affairs roles, including Head of Public Affairs at MSD Australia and New Zealand.​​

Samantha.png
Samantha Howell
Country Regulatory Head - Sanofi​
​

Sanofi's Country Regulatory Head for Australia and New Zealand since July 2025, after more than 13 years in regulatory affairs at the company. She rose from Regulatory Affairs Assistant in 2013 to Vaccines Regulatory Lead for Australia, New Zealand and South Korea.

​

​

Sponsorship

Sponsorship Opportunities 

We have a number of sponsorship packages available. Download the Sponsorship Prospectus HERE.

​

To discuss any sponsorship opportunities please contact Teva Smith on teva@dailydispatch.com.au

Program

Program

8.00 am - Arrival, networking and registration

9.00 am - Event commences

4.30 pm - Event concludes

6.00 pm - Networking reception

​

Full program timings will be confirmed shortly.

Register

Register

Register for the 2nd

AI Health Summit

Location
bottom of page